Nektar Therapeutics (NKTR) — Free Cash Flow Generation Index
Nektar Therapeutics (NKTR) has a Free Cash Flow Generation Index of 1.00x as of June 2018. Free cash flow of $956.90 Million represents 1% of operating cash flow ($959.64 Million). Explore reinvestment intensity of Nektar Therapeutics to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Nektar Therapeutics Free Cash Flow Generation Index (1997–2018)
Historical FCF Generation Index trend for Nektar Therapeutics across 4 annual periods. For the full cash flow conversion analysis, see Nektar Therapeutics (NKTR) cash flow conversion.
Annual Free Cash Flow Generation for Nektar Therapeutics (1997–2018)
Year-by-year Free Cash Flow Generation Index for Nektar Therapeutics. Check how aggressively does Nektar Therapeutics reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2018 | 0.98x | $703.98 Million | $718.21 Million | $14.24 Million | ▲ +104.6% |
| 2009 | 0.48x | $19.04 Million | $39.74 Million | $20.70 Million | ▼ -38.3% |
| 2007 | 0.78x | $113.51 Million | $146.30 Million | $32.80 Million | ▲ +131.5% |
| 1997 | -2.47x | $-12.28 Million | $4.98 Million | $17.26 Million | — |